Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

61. Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection (PubMed)

Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection Urinary tract infection (UTI) is one of the most common presentations in general practice and, in most instances, occurs in a single episode and is easily treated with a course of anti-microbial therapy. In the case of recurrent urinary tract infections, it is important to consider evaluation for any underlying causes. We report the case of a 32 year old female who had recurrent UTIs

Full Text available with Trip Pro

2017 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia

62. Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis

Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis 1 Public Summary Document Application No. 1439 – Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for painful bladder syndrome /interstitial cystitis and recurrent urinary tract infection and radiation induced cystitis Applicant: Juno (...) syndrome (PBS)/interstitial cystitis (IC), patients with recurrent urinary tract infections (rUTIs) and patients with radiation-induced cystitis, was received by the Department of Health from Juno Pharmaceuticals Pty Ltd. 2. MSAC’s advice to the Minister MSAC agreed that painful bladder syndrome/interstitial cystitis (PBS/IC), recurrent urinary tract infections (rUTIs) and radiation induced cystitis (RIC) can be debilitating conditions and there is a place for instillation of sodium hyaluronate

2017 Medical Services Advisory Committee

63. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. (PubMed)

Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. Objective To investigate whether symptomatic treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is non-inferior to antibiotics in the treatment of uncomplicated lower urinary tract infection (UTI) in women, thus offering an opportunity to reduce antibiotic use in ambulatory care.Design Randomised, double blind, non-inferiority trial.Setting 17 general

Full Text available with Trip Pro

2017 BMJ

64. Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection (PubMed)

Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection Enterococcus faecalis is a leading causative agent of catheter-associated urinary tract infection (CAUTI), the most common hospital-acquired infection. Its ability to grow and form catheter biofilm is dependent upon host fibrinogen (Fg). Examined here are how bacterial and host proteases interact with Fg and contribute to virulence. Analysis

Full Text available with Trip Pro

2017 NPJ biofilms and microbiomes

65. Urinary Tract Infection. (PubMed)

Urinary Tract Infection. Urinary tract infections (UTIs) are common in both inpatient and outpatient settings. This article provides an evidence-based, clinically relevant overview of management of UTIs, including screening, diagnosis, treatment, and prevention. Conditions covered include acute cystitis (both uncomplicated and complicated), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.

2017 Annals of Internal Medicine

66. Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinary tract infections

Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinary tract infections VABOMERE (meropenem and vaborbactam) Powder for Injection U.S. Department of Health and Human Services Search FDA Submit search VABOMERE (meropenem and vaborbactam) Powder for Injection VABOMERE Company: Rempex Pharmaceuticals, Inc. Application No.: 209776 Approval Date: 08/29/2017 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF

2017 FDA - Drug Approval Package

67. Probiotics for preventing urinary tract infection in people with neuropathic bladder. (PubMed)

Probiotics for preventing urinary tract infection in people with neuropathic bladder. Neuropathic or neurogenic bladder describes a process of dysfunctional voiding as the result of injury in the brain, spinal cord or nerves innervating the bladder. People with neuropathic bladder, such as from spinal cord injury (SCI), are at significant risk of morbidity from urinary tract infections (UTI). Effective methods to prevent UTI in people with SCI have been sought for many years. Probiotics (micro (...) -organisms that exert beneficial health effects in the host) have been recommended for bacterial interference of the urological tract to reduce colonisation by uropathogen and to manage the dual problems of infection and antibiotic resistance.This review looked at the benefits and harms of probiotics in preventing symptomatic UTI in people with neuropathic bladder compared with placebo, no therapy, or non-antibiotic prophylaxis (cranberry juice, methenamine hippurate, topical oestrogen).We searched

Full Text available with Trip Pro

2017 Cochrane

68. The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long-term antibiotic therapy

The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long-term antibiotic therapy "The efficacy of D-mannose in the prevention of recurrent urinary tract" by Kristine Stompro < > > > > > Title Author Date of Graduation Summer 8-12-2017 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background: Recurrent urinary tract infections are a significant problem in women and the current mainstay (...) of prophylactic therapy is long-term antibiotic use. Based on recent studies, there is a possible natural remedy that could reduce the use of antibiotics for preventative medicine in recurrent urinary tract infections. This would decrease the chance of antibiotic resistance and the side effects of the antibiotics to the user. Methods: An exhaustive search of CINAHL, MEDLINE-Ovid, MEDLINE-PubMed, and Web of Science with the search terms “D-mannose” and “recurrent urinary tract infection” was performed

2017 Pacific University EBM Capstone Project

69. Elevated antibiotic resistance of Sudanese urinary tract infection bacteria (PubMed)

Elevated antibiotic resistance of Sudanese urinary tract infection bacteria This study determined the prevalence of urinary tract infections in the Sudanese state of Khartoum and antimicrobial susceptibility pattern of isolated bacterial species. 200 adult patient urine specimens were collected and cultivated to identify the growing bacteria and their susceptibility to antibiotics. 35 % of specimens had significant bacterial growth. The most frequent isolates in this study were E. coli, E

Full Text available with Trip Pro

2017 EXCLI journal

70. NSAIDs as treatment for uncomplicated urinary tract infections

NSAIDs as treatment for uncomplicated urinary tract infections NSAIDs as treatment for uncomplicated urinary tract infections – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2017\/06\/mo2017-5.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Jun 09 2017 NSAIDs as treatment for uncomplicated (...) urinary tract infections By in , , Journal reference: Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. Bmj 2015 Dec 23;351:h6544. Link: Published: December 2015 Evidence cookie says… NSAIDs should not be recommended as a first line treatment for uncomplicated UTIs in women compared with women who received empirical antibiotics, those who received regular

Full Text available with Trip Pro

2017 Morsels of Evidence

71. NSAIDs as treatment for uncomplicated urinary tract infections

NSAIDs as treatment for uncomplicated urinary tract infections NSAIDs as treatment for uncomplicated urinary tract infections – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2017\/06\/mo2017-5.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Jun 09 2017 NSAIDs as treatment for uncomplicated (...) urinary tract infections By in , , Journal reference: Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. Bmj 2015 Dec 23;351:h6544. Link: Published: December 2015 Evidence cookie says… NSAIDs should not be recommended as a first line treatment for uncomplicated UTIs in women compared with women who received empirical antibiotics, those who received regular

Full Text available with Trip Pro

2017 Morsels of Evidence

72. A 5-day antibiotic course for treatment of intermittent catheter-associated urinary tract infection in patients with spinal cord injury (PubMed)

A 5-day antibiotic course for treatment of intermittent catheter-associated urinary tract infection in patients with spinal cord injury This was a retrospective monocentric study conducted at Centre Calvé, France, with the objective of evaluating the effectiveness of a 5-day course of antibiotics for symptomatic (mild urinary tract infection, UTI) or asymptomatic (aBact) bacteriuria in patients with spinal cord injury on intermittent catheterization.This study was conducted from May 2013

Full Text available with Trip Pro

2017 Spinal cord series and cases

78. Uncomplicated urinary tract infection (UTI) (pyelonephritis and cystitis)

Uncomplicated urinary tract infection (UTI) (pyelonephritis and cystitis)

2017 DynaMed Plus